164 related articles for article (PubMed ID: 15519475)
1. Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.
Clarebout G; Nativelle E; Bozdogan B; Villers C; Leclercq R
Int J Antimicrob Agents; 2004 Nov; 24(5):444-9. PubMed ID: 15519475
[TBL] [Abstract][Full Text] [Related]
2. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence.
López F; Culebras E; Betriú C; Rodríguez-Avial I; Gómez M; Picazo JJ
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):73-7. PubMed ID: 18653303
[TBL] [Abstract][Full Text] [Related]
4. Correlation of agar dilution and VITEK2 system for detection of resistance to macrolides, lincosamides and pristinamycin among Staphylococcus aureus and Staphylococcus epidermidis: association with genotypes.
Bémer P; Juvin ME; Corvec S; Ros A; Drugeon H
Clin Microbiol Infect; 2005 Aug; 11(8):656-61. PubMed ID: 16008619
[TBL] [Abstract][Full Text] [Related]
5. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece.
Spiliopoulou I; Petinaki E; Papandreou P; Dimitracopoulos G
J Antimicrob Chemother; 2004 May; 53(5):814-7. PubMed ID: 15056638
[TBL] [Abstract][Full Text] [Related]
6. [MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Szymanek K; Bilewska A; Pupek J; Luczak M
Med Dosw Mikrobiol; 2006; 58(3):199-205. PubMed ID: 17340994
[TBL] [Abstract][Full Text] [Related]
7. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
8. Unusual inducible cross resistance to macrolides, lincosamides, and streptogramins B by methylase production in clinical isolates of Staphylococcus aureus.
Clarebout G; Nativelle E; Leclercq R
Microb Drug Resist; 2001; 7(4):317-22. PubMed ID: 11822771
[TBL] [Abstract][Full Text] [Related]
9. Distribution of genes encoding resistance to macrolides, lincosamides and streptogramins among clinical staphylococcal isolates in a Turkish university hospital.
Cetin ES; Gunes H; Kaya S; Aridogan BC; Demirci M
J Microbiol Immunol Infect; 2010 Dec; 43(6):524-9. PubMed ID: 21195981
[TBL] [Abstract][Full Text] [Related]
10. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
Bozdogan B; Leclercq R
Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
[TBL] [Abstract][Full Text] [Related]
11. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of erm genes encoding macrolide-lincosamide-streptogramin (MLS) resistance among clinical isolates of Staphylococcus aureus in a Turkish university hospital.
Saribas Z; Tunckanat F; Pinar A
Clin Microbiol Infect; 2006 Aug; 12(8):797-9. PubMed ID: 16842577
[TBL] [Abstract][Full Text] [Related]
13. Subinhibitory quinupristin/dalfopristin attenuates virulence of Staphylococcus aureus.
Koszczol C; Bernardo K; Krönke M; Krut O
J Antimicrob Chemother; 2006 Sep; 58(3):564-74. PubMed ID: 16895938
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions.
Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N
Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208
[TBL] [Abstract][Full Text] [Related]
15. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of constitutively expressed erm(C) genes selected in vitro in the presence of the non-inducers pirlimycin, spiramycin and tylosin.
Lüthje P; Schwarz S
J Antimicrob Chemother; 2007 Jan; 59(1):97-101. PubMed ID: 17085767
[TBL] [Abstract][Full Text] [Related]
18. Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy.
Gherardi G; De Florio L; Lorino G; Fico L; Dicuonzo G
FEMS Immunol Med Microbiol; 2009 Jan; 55(1):62-7. PubMed ID: 19076222
[TBL] [Abstract][Full Text] [Related]
19. Resistance to macrolide, lincosamide and streptogramin antibiotics in staphylococci isolated in Istanbul, Turkey.
Aktas Z; Aridogan A; Kayacan CB; Aydin D
J Microbiol; 2007 Aug; 45(4):286-90. PubMed ID: 17846580
[TBL] [Abstract][Full Text] [Related]
20. Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.
Dupuis M; Leclercq R
Antimicrob Agents Chemother; 2006 Jan; 50(1):237-42. PubMed ID: 16377692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
